KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Investing Activities: 2017-2025

Historic Cash from Investing Activities for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$14.3 million.

  • Guardant Health's Cash from Investing Activities rose 95.13% to -$14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $288.4 million, marking a year-over-year decrease of 26.36%. This contributed to the annual value of -$261.3 million for FY2024, which is 131.10% down from last year.
  • Per Guardant Health's latest filing, its Cash from Investing Activities stood at -$14.3 million for Q3 2025, which was down 34.75% from -$10.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash from Investing Activities registered a high of $663.5 million during Q4 2023, and its lowest value of -$294.8 million during Q3 2024.
  • For the 3-year period, Guardant Health's Cash from Investing Activities averaged around $77.9 million, with its median value being $10.5 million (2024).
  • As far as peak fluctuations go, Guardant Health's Cash from Investing Activities plummeted by 230.80% in 2023, and later skyrocketed by 979.11% in 2025.
  • Quarterly analysis of 5 years shows Guardant Health's Cash from Investing Activities stood at -$266.7 million in 2021, then spiked by 126.48% to $70.6 million in 2022, then spiked by 839.38% to $663.5 million in 2023, then slumped by 98.41% to $10.5 million in 2024, then skyrocketed by 95.13% to -$14.3 million in 2025.
  • Its Cash from Investing Activities was -$14.3 million in Q3 2025, compared to -$10.6 million in Q2 2025 and $302.9 million in Q1 2025.